In Syria, 15 new cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were reported in the past week, bringing the total number of cVDPV2 cases in the country to 17. Sixteen of the 17 cases are from Mayadeen district, Deir-Al-Zour governorate, and one case is from Raqua district, Raqua governorate. All cases had onset of paralysis between 3 March and 23 May.
The 14th report of the Independent Monitoring Board (IMB) has been published, following the group’s meeting in May.
Important lessons on stopping the poliovirus in the most challenging locations are moving the polio eradication programme closer to the finishing line.
In recent years, the global drive to eradicate polio has seen the virus cornered in fewer places than ever before. Yet polio’s final strongholds are some of the most complicated places in the world to deliver vaccination campaigns. Insecurity and conflict are some of the challenges to delivering vaccines, as well as populations on the move, testing terrain and weather, and weak health systems.
In Syria, a circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak has been confirmed. The virus strain was isolated from two cases of acute flaccid paralysis (AFP) and one healthy contact, from Deir-Ez-Zor governorate. See the ‘Syrian Arab Republic’ section below for more information.
Circulating vaccine-derived poliovirus type 2 outbreak has been confirmed in Deir-Ez-Zor Governorate
A circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak has been confirmed in the Deir-Ez-Zor Governorate of the Syrian Arab Republic. The virus strain was isolated from two cases of acute flaccid paralysis (AFP), with onset of paralysis on 5 March and 6 May, as well as from a healthy child in the same community.